Chemokines and Immune Cells in Hind Limb Ischemia
Chemokines and Immune Cells in Hind Limb Ischemia
批准号:
6786708
负责人:
PAULA K SHIREMAN
金额:
$29.2万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2007-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
New treatments are needed to decrease the complications of atherosclerosis, which include death, disability, heart attack, and amputation. Notably, collateral artery formation that "naturally" bypasses arterial obstructions occurs in all patients, but to a variable degree. Understanding the mechanisms of collateral artery formation and ischemic tissue necrosis could lead to new primary and adjuvant therapies for atherosclerosis. My long term research goal is to understand the basic mechanisms underlying collateral artery formation and tissue necrosis and specifically, in this application, ! will determine the influence of the immune system in collateral artery formation and tissue necrosis secondary to ischemia. Central to my hypothesis is that the recruitment and activation of inflammatory cells and the concomitant immune response influences collateral artery formation and susceptibility to tissue necrosis. I hypothesize that 1) immune differences account for their differential susceptibility to tissue necrosis in two inbred mouse strains, 2) T-cell recruitment and activation is an important determinant of susceptibility to tissue necrosis and 3) the MCP-1/CCR2 axis is an important determinant of susceptibility to tissue necrosis. Monocyte Chemoattractant Protein-1 (MCP-1) and its receptor CCR2 are important regulators of immune cell recruitment and differentiation. To test these hypotheses, I have in preliminary studies a) developed a mouse hind limb model of ischemia and have demonstrated that inbred strains of mice have differential susceptibilities to tissue necrosis; b) demonstrated that nude mice lacking T-cells and mice lacking MCP-1 or CCR2 have an increased incidence and severity of tissue necrosis as compared to wild type controls and c) shown that there is an increased recruitment of inflammatory cells to the ischemic hind limb. To test my hypothesis, I have proposed three specific aims. In aim #1, I will identify the mechanisms underlying the differential susceptibility to tissue necrosis in two inbred strains of mice. In aim #2, I will determine the role of T-cells and the Thl/Th2 immune response in tissue necrosis and in aim #3 I will determine the role of the MCP-1tCCR2 axis in tissue necrosis by using mice that are genetically inactivated for CCR2 and its ligand, MCP-1. The experiments outlined in this proposal are innovative because they utilize the power of genetic knockout mice in a hind limb ischemia model. I have assembled an experienced team of researchers in the diverse areas of vascular biology, immunology and physiology to test these hypotheses. The significance of this research is that a better understanding of the mechanisms of collateral artery formation and susceptibility to tissue necrosis could lead to the design of novel primary or adjuvant treatments for atherosclerotic occlusive disease and thereby decrease death and disability rates from myocardial infarction and amputations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Harnessing the power of CTSA-CDRN data networks: Using social determinants of health, frailty and functional status to identify at-risk patients and improve risk adjustment
-
批准号:10199784
-
项目类别:
-
资助金额:$75.0万
-
财政年份:2018
-
负责人:PAULA K SHIREMAN
-
依托单位:
Harnessing the power of CTSA-CDRN data networks: Using social determinants of health, frailty and functional status to identify at-risk patients and improve risk adjustment
-
批准号:9981049
-
项目类别:
-
资助金额:$75.49万
-
财政年份:2018
-
负责人:PAULA K SHIREMAN
-
依托单位:
Research Education Component
-
批准号:10670119
-
项目类别:
-
资助金额:$25.02万
-
财政年份:2015
-
负责人:PAULA K SHIREMAN
-
依托单位:
Research Education Component
-
批准号:10455763
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2015
-
负责人:PAULA K SHIREMAN
-
依托单位:
Research Education Component
-
批准号:10221553
-
项目类别:
-
资助金额:$27.05万
-
财政年份:2015
-
负责人:PAULA K SHIREMAN
-
依托单位:
MicroRNA Regulation of Macrophage Polarization in Muscle Regeneration
-
批准号:8598034
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAULA K SHIREMAN
-
依托单位:
MicroRNA Regulation of Macrophage Polarization in Muscle Regeneration
-
批准号:8240594
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAULA K SHIREMAN
-
依托单位:
MicroRNA Regulation of Macrophage Polarization in Muscle Regeneration
-
批准号:8391644
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:PAULA K SHIREMAN
-
依托单位:
Chemokines and Immune Cells in Hind Limb Ischemia
-
批准号:7119321
-
项目类别:
-
资助金额:$7.3万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
CHEMOKINES AND IMMUNE CELLS IN HIND LIMB ISCHEMIA
-
批准号:7622550
-
项目类别:
-
资助金额:$37.1万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
CHEMOKINES AND IMMUNE CELLS IN HIND LIMB ISCHEMIA
-
批准号:7856125
-
项目类别:
-
资助金额:$16.63万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
Chemokines and Immune Cells in Hind Limb Ischemia
-
批准号:6675507
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
CHEMOKINES AND IMMUNE CELLS IN HIND LIMB ISCHEMIA
-
批准号:7461363
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
CHEMOKINES AND IMMUNE CELLS IN HIND LIMB ISCHEMIA
-
批准号:7874467
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
Chemokines and Immune Cells in Hind Limb Ischemia
-
批准号:6935939
-
项目类别:
-
资助金额:$29.2万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
Chemokines and Immune Cells in Hind Limb Ischemia
-
批准号:7105564
-
项目类别:
-
资助金额:$35.64万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
Chemokines and Immune Cells in Hind Limb Ischemia
-
批准号:7489728
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
CHEMOKINES AND IMMUNE CELLS IN HIND LIMB ISCHEMIA
-
批准号:8103860
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2003
-
负责人:PAULA K SHIREMAN
-
依托单位:
The Chemokine System in Collateral Artery Formation
-
批准号:6902615
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2002
-
负责人:PAULA K SHIREMAN
-
依托单位:
The Chemokine System in Collateral Artery Formation
-
批准号:6758643
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2002
-
负责人:PAULA K SHIREMAN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: